Clinical Trials Logo

Clinical Trial Summary

Chest tubes are used for air or fluid removal from the pleural space. When a chest tube is placed, it can be hard for the fluid to drain.Tissue plasminogen activator (tPA) and DNase are given through the chest tube to help with draining the fluid. We are doing this research to see if early addition of tPA-DNase immediately after chest tube placement will help with better fluid draining.


Clinical Trial Description

The purpose of this study is to determine the timing and efficacy of early administration and late administration of t-PA/DNase via thoracostomy (n=60). Patients will be identified from the Intensive Care Unit, Coronary Care Unit, and wards/stepdown units. Prior to chest tube placement, patients will be randomized to one of the two treatment arms (early use of t-PA-DNase verus late use of t-PA-DNase). Route of administration will be via their thoracostomy tube over a period of three days twice daily. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03167281
Study type Interventional
Source Prisma Health-Midlands
Contact
Status Withdrawn
Phase Phase 4
Start date February 17, 2017
Completion date March 10, 2021

See also
  Status Clinical Trial Phase
Completed NCT01597336 - Treatment of Abdominal Abscesses With or Without Fibrinolysis N/A